| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f340bc6c73720402ac16e460a3d27ebb |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-26 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N63-00 |
| filingDate |
1999-12-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2004-01-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_434ee0ed61f7c6cfd4ed854ee2928720 |
| publicationDate |
2004-01-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-6680052-B1 |
| titleOfInvention |
Methods of inhibiting tumor growth using adenosine receptor activated cells |
| abstract |
Methods of treating and/or imaging tumors utilize A 1 adenosine-receptor activated cells (such as monocytes and macrophages) are described. Activated cells may be administered systemically or locally, and may be radiolabelled to provide imaging and diagnostic functions. Macrophages resident in tissues may be primed and activated for use in treating and imaging tumors. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005075308-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8247231-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1651259-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1651259-A4 |
| priorityDate |
1999-11-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |